E-cigarette Company Vaporized Invests £2 Million in Production
E-cigarette company Vaporized invests £2 million in production. According to Daily Business, e-cigarette company Vaporized has invested £2 million at its headquarters in Edinburgh, UK, to meet growing demand. The company develops and manufactures e-cigare
The e-cigarette company Vaporized has invested £2 million in production, according to Daily Business. The company has invested £2 million at its headquarters in Edinburgh, UK, to meet the growing demand.
The company develops and produces e-cigarettes and e-liquids for major American brands such as Arc Distro, Bad Drip, and Charlies Chalkdust.
Latest data shows that nearly 3 million people are now vaping. Subsequently, the company announced this investment.
Doug Mutter, a director at Vaporized, stated: 'We are implementing ambitious growth plans, aiming to triple our factory space and double our workforce to 1,000 people over the next three years. This investment will create 20 new specialized jobs, ensuring we can meet customer demand.'
Mr. Mutter continued: 'Investing in our manufacturing and product development expertise can provide us with a real competitive advantage. More and more smokers are becoming aware of evidence-based public health opportunities, and international brands are responding to the growing consumer demand. We believe this is a genuine growth area.'
The company develops and produces e-cigarettes and e-liquids for major American brands such as Arc Distro, Bad Drip, and Charlies Chalkdust.
Latest data shows that nearly 3 million people are now vaping. Subsequently, the company announced this investment.Doug Mutter, a director at Vaporized, stated: 'We are implementing ambitious growth plans, aiming to triple our factory space and double our workforce to 1,000 people over the next three years. This investment will create 20 new specialized jobs, ensuring we can meet customer demand.'
Mr. Mutter continued: 'Investing in our manufacturing and product development expertise can provide us with a real competitive advantage. More and more smokers are becoming aware of evidence-based public health opportunities, and international brands are responding to the growing consumer demand. We believe this is a genuine growth area.'



